Skip to main content
. 2018 Aug 22;2018(8):CD001955. doi: 10.1002/14651858.CD001955.pub4

Comparison 2. Any glucocorticoid compared to epinephrine.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Croup score (change baseline ‐ 2 hours) by inpatient/outpatient 2 130 Std. Mean Difference (IV, Random, 95% CI) 0.77 [‐0.24, 1.77]
1.1 Inpatient 1 66 Std. Mean Difference (IV, Random, 95% CI) 0.26 [‐0.22, 0.75]
1.2 Outpatient 1 64 Std. Mean Difference (IV, Random, 95% CI) 1.29 [0.73, 1.84]
2 Croup score (change baseline ‐ 6 hours) by inpatient/outpatient 2 63 Std. Mean Difference (IV, Random, 95% CI) ‐0.10 [‐1.18, 0.97]
2.1 Inpatient 2 63 Std. Mean Difference (IV, Random, 95% CI) ‐0.10 [‐1.18, 0.97]
3 Croup score (change baseline ‐ 12 hours) by inpatient/outpatient 3 129 Std. Mean Difference (IV, Random, 95% CI) ‐0.07 [‐0.57, 0.43]
3.1 Inpatient 3 129 Std. Mean Difference (IV, Random, 95% CI) ‐0.07 [‐0.57, 0.43]
4 Croup score (change baseline ‐ 24 hours) by inpatient/outpatient 3 129 Std. Mean Difference (IV, Random, 95% CI) 0.17 [‐0.18, 0.51]
4.1 Inpatient 3 129 Std. Mean Difference (IV, Random, 95% CI) 0.17 [‐0.18, 0.51]
5 Croup score (change baseline ‐ 2 hours) by glucocorticoid 2 130 Std. Mean Difference (IV, Random, 95% CI) 0.88 [0.13, 1.63]
5.1 Budesonide 1 66 Std. Mean Difference (IV, Random, 95% CI) 0.26 [‐0.22, 0.75]
5.2 Dexamethasone 1 31 Std. Mean Difference (IV, Random, 95% CI) 1.13 [0.35, 1.91]
5.3 Beclomethasone 1 33 Std. Mean Difference (IV, Random, 95% CI) 1.41 [0.62, 2.19]
6 Croup score (change baseline ‐ 12 hours) by glucocorticoid 3 129 Std. Mean Difference (IV, Random, 95% CI) ‐0.07 [‐0.57, 0.43]
6.1 Budesonide 1 66 Std. Mean Difference (IV, Random, 95% CI) 0.02 [‐0.47, 0.50]
6.2 Dexamethasone 2 63 Std. Mean Difference (IV, Random, 95% CI) ‐0.14 [‐1.09, 0.82]
7 Croup score (change baseline ‐ 24 hours) by glucocorticoid 3 129 Std. Mean Difference (IV, Random, 95% CI) 0.17 [‐0.18, 0.51]
7.1 Budesonide 1 66 Std. Mean Difference (IV, Random, 95% CI) 0.21 [‐0.27, 0.70]
7.2 Dexamethasone 2 63 Std. Mean Difference (IV, Random, 95% CI) 0.12 [‐0.38, 0.61]
8 Return visits or (re)admissions or both by inpatient/outpatient 2 130 Risk Difference (M‐H, Random, 95% CI) 0.0 [‐0.04, 0.04]
8.1 Inpatient 1 66 Risk Difference (M‐H, Random, 95% CI) 0.0 [‐0.06, 0.06]
8.2 Outpatient 1 64 Risk Difference (M‐H, Random, 95% CI) 0.0 [‐0.06, 0.06]
9 Length of stay by inpatient/outpatient 1 32 Mean Difference (IV, Random, 95% CI) ‐10.0 [‐33.89, 13.89]
9.1 Inpatient 1 32 Mean Difference (IV, Random, 95% CI) ‐10.0 [‐33.89, 13.89]
10 Additional treatments: use of epinephrine 1 66 Risk Ratio (M‐H, Random, 95% CI) 0.30 [0.03, 2.69]
11 Additional treatments: intubation/tracheostomy 1 66 Risk Difference (M‐H, Random, 95% CI) 0.0 [‐0.06, 0.06]
12 Additional treatments: supplemental glucocorticoids 1 66 Risk Ratio (M‐H, Random, 95% CI) 0.83 [0.48, 1.43]